Fidelity Disruptive Medicine ETF Rating $29.24 -0.14 (-0.48%) As of 07/2/2026 03:56 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.71Holdings in FMED have an aggregate rating of Moderate Buy based on 424 analyst ratings issued in the past year covering 23 companies (54.8% of the portfolio).FMED Aggregate Price Target$29.24High Prediction$29.24Average Prediction$29.24Low Prediction$29.24Holdings in FMED have an aggregate price target of $29.24 and a range of $29.24 to $29.24 covering 23 companies (54.8% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 FMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.99%LFSTLifeStance Health Group$11.273.1596 of 5 stars2.91$9.75 -13.5%11Analyst UpgradeInsider TradeGap Up3.48%TXG10x Genomics$39.011.7888 of 5 stars2.20$25.92 -33.6%15Analyst Forecast3.30%DHRDanaher$197.850.0%4.5379 of 5 stars2.80$233.61 18.1%25Positive News2.85%COGTCogent Biosciences$38.691.4534 of 5 stars2.86$43.73 13.0%142.57%ISRGIntuitive Surgical$426.014.3495 of 5 stars2.67$573.42 34.6%27Trending NewsAnalyst Revision2.54%ALNYAlnylam Pharmaceuticals$312.784.2448 of 5 stars2.85$461.39 47.5%26Analyst RevisionGap Down2.51%MRNAModerna$79.761.1686 of 5 stars1.83$37.13 -53.4%18Trending NewsGap Down2.45%ARGXargenex$939.683.67 of 5 stars2.92$1,034.56 10.1%24Analyst Forecast2.38%TECHBio-Techne$70.831.6432 of 5 stars2.33$67.79 -4.3%18Analyst Downgrade2.31%LEGNLegend Biotech$29.913.1043 of 5 stars2.67$60.23 101.4%152.27%KYMRKymera Therapeutics$113.511.8201 of 5 stars2.96$121.41 7.0%23Trending NewsAnalyst ForecastInsider Trade2.24%TMOThermo Fisher Scientific$522.38-0.2%4.8409 of 5 stars2.85$605.09 15.8%26Positive News2.24%UNHUnitedHealth Group$424.64-0.2%4.6015 of 5 stars2.81$411.42 -3.1%27Trending NewsAnalyst Forecast2.09%ASNDAscendis Pharma A/S$274.504.1402 of 5 stars3.00$295.39 7.6%19Analyst Upgrade2.04%EWEdwards Lifesciences$94.31-0.1%3.2305 of 5 stars2.81$96.39 2.2%27Analyst ForecastGap Down1.99%HTFLHeartflow$27.973.5457 of 5 stars2.70$37.00 32.3%10News CoverageAnalyst Upgrade1.93%RVMDRevolution Medicines$189.241.8894 of 5 stars3.00$135.39 -28.5%22News CoverageAnalyst ForecastInsider Trade1.90%CAICaris Life Sciences$18.304.096 of 5 stars2.45$27.56 50.6%11Analyst ForecastGap Up1.82%XENEXenon Pharmaceuticals$60.963.9997 of 5 stars3.00$77.20 26.6%17News CoveragePositive News1.77%NTRANatera$279.321.7222 of 5 stars2.86$260.33 -6.8%221.76%VCYTVeracyte$57.081.5861 of 5 stars2.56$50.43 -11.7%9News CoverageGap Up1.72%PCVXVaxcyte$58.392.0318 of 5 stars2.63$86.00 47.3%8Gap Down1.65%ALHCAlignment Healthcare$23.803.5429 of 5 stars2.80$24.30 2.1%10Insider Trade This page (NASDAQ:FMED) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FMED Stock Alerts